These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 25754634

  • 1. Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?
    Aznar MC, Maraldo MV, Schut DA, Lundemann M, Brodin NP, Vogelius IR, Berthelsen AK, Specht L, Petersen PM.
    Int J Radiat Oncol Biol Phys; 2015 May 01; 92(1):169-74. PubMed ID: 25754634
    [Abstract] [Full Text] [Related]

  • 2. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
    Filippi AR, Ragona R, Piva C, Scafa D, Fiandra C, Fusella M, Giglioli FR, Lohr F, Ricardi U.
    Int J Radiat Oncol Biol Phys; 2015 May 01; 92(1):161-8. PubMed ID: 25863763
    [Abstract] [Full Text] [Related]

  • 3. A case study evaluating deep inspiration breath-hold and intensity-modulated radiotherapy to minimise long-term toxicity in a young patient with bulky mediastinal Hodgkin lymphoma.
    Tomaszewski JM, Crook S, Wan K, Scott L, Foroudi F.
    J Med Radiat Sci; 2017 Mar 01; 64(1):69-75. PubMed ID: 28188697
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma.
    Starke A, Bowden J, Lynn R, Hall K, Hudson K, Rato A, Aldridge E, Robb D, Steele P, Brady J, Mikhaeel NG.
    Radiother Oncol; 2018 Dec 01; 129(3):449-455. PubMed ID: 30245037
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Abdominal DIBH reduces the cardiac dose even further: a prospective analysis.
    Zhao F, Shen J, Lu Z, Luo Y, Yao G, Bu L, Ge J, Yang X, Ning L, Yan S.
    Radiat Oncol; 2018 Jun 22; 13(1):116. PubMed ID: 29929560
    [Abstract] [Full Text] [Related]

  • 9. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.
    Corradini S, Ballhausen H, Weingandt H, Freislederer P, Schönecker S, Niyazi M, Simonetto C, Eidemüller M, Ganswindt U, Belka C.
    Strahlenther Onkol; 2018 Mar 22; 194(3):196-205. PubMed ID: 28916844
    [Abstract] [Full Text] [Related]

  • 10. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
    Weber DC, Johanson S, Peguret N, Cozzi L, Olsen DR.
    Int J Radiat Oncol Biol Phys; 2011 Oct 01; 81(2):490-7. PubMed ID: 20800383
    [Abstract] [Full Text] [Related]

  • 11. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):260-7. PubMed ID: 22014950
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
    Maraldo MV, Dabaja BS, Filippi AR, Illidge T, Tsang R, Ricardi U, Petersen PM, Schut DA, Garcia J, Headley J, Parent A, Guibord B, Ragona R, Specht L.
    Int J Radiat Oncol Biol Phys; 2015 May 01; 92(1):144-52. PubMed ID: 25670544
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
    Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, Joyce M, Sandler E, Li Z, Mendenhall NP.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):449-55. PubMed ID: 22386373
    [Abstract] [Full Text] [Related]

  • 18. Left-sided breast cancer loco-regional radiotherapy with deep inspiration breath-hold: Does volumetric-modulated arc radiotherapy reduce heart dose further compared with tangential intensity-modulated radiotherapy?
    Pham TT, Ward R, Latty D, Owen C, Gebski V, Chojnowski J, Kelly C, Ahern V, Tiver K, Stuart K, Wang W.
    J Med Imaging Radiat Oncol; 2016 Aug 01; 60(4):545-53. PubMed ID: 27094588
    [Abstract] [Full Text] [Related]

  • 19. Dosimetric comparison of moderate deep inspiration breath-hold and free-breathing intensity-modulated radiotherapy for left-sided breast cancer.
    Chi F, Wu S, Zhou J, Li F, Sun J, Lin Q, Lin H, Guan X, He Z.
    Cancer Radiother; 2015 May 01; 19(3):180-6. PubMed ID: 25921618
    [Abstract] [Full Text] [Related]

  • 20. A comparative analysis of 3D conformal deep inspiratory-breath hold and free-breathing intensity-modulated radiation therapy for left-sided breast cancer.
    Reardon KA, Read PW, Morris MM, Reardon MA, Geesey C, Wijesooriya K.
    Med Dosim; 2013 May 01; 38(2):190-5. PubMed ID: 23453454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.